Evidence map›Paper›PMID 38771441›Full record

ArticleSurgical case reports2024

A first report of right-hemicolectomy for ascending colon cancer in Japan with the da Vinci SP surgical robot system.

Ai Noda, Koichi Okuya, Emi Akizuki, Masaaki Miyo, Masayuki Ishii, Ryo Miura, Momoko Ichihara, Maho Toyota, Tatsuya Ito, Tadashi Ogawa and 2 more

Abstract read
In one paragraph

Article in Surgical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Application of the Da Vinci Single-Port (SP) Robot in General Surgery: A First Systematic Review.The international journal of medical robotics + computer assisted surgery : MRCAS · 2025
    Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ai NodaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Koichi OkuyaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Emi AkizukiDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Masaaki MiyoDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Masayuki IshiiDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Ryo MiuraDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Momoko IchiharaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Maho ToyotaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Tatsuya ItoDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Tadashi OgawaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Akina KimuraDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Ichiro TakemasaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, 291 S1 W16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan. itakemasa@sapmed.ac.jp.ORCID http://orcid.org/0000-0003-1595-2453

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe da Vinci SP robotic surgical system received regulatory approval for use in colorectal cancer surgery in Japan in April 2023. Given the advantages of the precision of a robot and the postoperative cosmesis of single-site surgery, the system is expected to be further utilized for minimally invasive surgeries, in addition to the curative and safety-assured laparoscopic technique. CASE PRESENTATION: A 73-year-old man presented at our hospital with positive fecal occult blood. He was diagnosed with cT2N0M0 (Stage I) ascending colon cancer and underwent a right hemicolectomy, which was performed with the da Vinci SP system. The operation was performed safely, and the patient was discharged without complications. Pathology findings showed that complete mesocolic excision was achieved.

conclusionsHerein, we report the first colorectal cancer surgery performed using the da Vinci SP system in Japan. The use of this robotic surgical system with access forms for right hemicolectomy is safe and oncologically appropriate.

Indexed as

Ascending colon cancerMinimally invasive surgeryRight colectomyRobotic single-incision laparoscopic surgeryRobotic surgerySingle-port colectomy

Identifiers

PMID38771441
PMCPMC11109069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.